Home › Quitting Smoking (Tobacco Use Disorder) › NCT07564648
Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability
Who can join
Ages 21 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Aged 21 years or older * Currently smoke cigarettes daily (≥ 5 cigarettes/day) for at least the past 6 months, and their usual brand is menthol cigarettes * Willing to provide informed consent * Willing to abstain from all nicotine, tobacco, and smoked cannabis products for approximately 12 hours prior to each study visit * Own and regularly use a functional smartphone compatible with study procedures (e.g., completing daily assessments) * Willing to complete two weeks of daily assessments involving use of their usual brand menthol cigarettes and the study product * Able to read, speak, and understand English Exclusion Criteria: * Current diagnosis of any significant lung diseases (e.g., asthma, chronic obstructive pulmonary disease, cystic fibrosis) * History of a cardiac event or episode of cardiac distress (e.g., heart attack, hospitalization for chest pain) within the past 3 months * Currently pregnant, planning to become pregnant during the study period, or currently breastfeeding * Self-reported use of any non-cigarette nicotine or tobacco product (e.g., e-cigarettes, cigars, oral nicotine products) or cannabis on more than 10 days in the past 30 days * Self-reported current participation in a smoking cessation program or intention to quit smoking in the next 3 months * Self-reported difficulty with blood draws
About the study
This randomized, double-blind, crossover human laboratory study compares the abuse liability of cigarettes containing menthol and non-menthol cigarette variants, using the participant's usual brand menthol cigarette as a within-subject reference. Participants complete standardized laboratory smoking sessions, behavioral economic tasks, and a naturalistic observational period. The study examines differences in nicotine delivery, smoking behavior, and subjective effects across cigarette types in laboratory and real-world contexts.
What is being tested
- Biospecimen Collection (behavioral)
- Questionnaire Administration (behavioral)
- Cigarette Purchase Task (behavioral)
- Cross-Price Elasticity Task (behavioral)
- Daily Diary Surveys (behavioral)
- Progressive Ratio Task (behavioral)
Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 48 · Started: Aug 18, 2026
Contact the study team
- The Ohio State University Comprehensive Cancer Center · Phone: 800-293-5066
Official record on ClinicalTrials.gov — NCT07564648
Locations in the U.S.
| Ohio | Ohio State University Comprehensive Cancer Center, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.